Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax and Emory University to Collaborate on HPV Therapeutic Program for Head and Neck Cancers

GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc....
July 09, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present at the American Society for Virology 2018 Annual Meeting

ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...
May 30, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present at the 2018 ASM Microbe Conference

ATLANTA, GA. , May 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” Vaccine Industry Excellence Award at the World Vaccine Congress, announced today...
May 24, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Awarded NIH Grant for Novel Zika Vaccine

ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and...
May 22, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7

CEO Robert McNally to Speak as part of BIO’s One Health Day Program ATLANTA, GA., May 22, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
May 03, 2018 13:00 ET | Source: GeoVax, Inc.

GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates

ATLANTA, May 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
April 19, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax to Present its MVA Vector Platform Technology at Vaccinology Conference

ATLANTA, GA, April 19, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that its Chief Scientific Officer, Dr. Farshad...
April 10, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Awarded NIH Fast Track Phase I/II Grant to Advance Lassa Fever Vaccine

Deadly epidemic continues in Nigeria; Lassa virus remains endemic in West Africa ATLANTA, GA, April 10, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing...
April 05, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress

ATLANTA, GA, April 05, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to announce that it won “Best Biotech” at the World...
March 28, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Provides Vaccine Development Update

ATLANTA, GA, March 28, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today...